Order Article Reprints

Chiu H-W, Chang J-S, Lin H-Y, Lee H-H, Kuei C-H, Lin C-H, Huang H-M, Lin Y-F. FBXL7 Upregulation Predicts a Poor Prognosis and Associates with a Possible Mechanism for Paclitaxel Resistance in Ovarian Cancer. Journal of Clinical Medicine. 2018; 7(10):330. https://doi.org/10.3390/jcm7100330

Chiu, Hui-Wen, Jeng-Shou Chang, Hui-Yu Lin, Hsun-Hua Lee, Chia-Hao Kuei, Che-Hsuan Lin, Huei-Mei Huang, and Yuan-Feng Lin. 2018. "FBXL7 Upregulation Predicts a Poor Prognosis and Associates with a Possible Mechanism for Paclitaxel Resistance in Ovarian Cancer" Journal of Clinical Medicine 7, no. 10: 330. https://doi.org/10.3390/jcm7100330

Chiu, H.-W., Chang, J.-S., Lin, H.-Y., Lee, H.-H., Kuei, C.-H., Lin, C.-H., Huang, H.-M., & Lin, Y.-F. (2018). FBXL7 Upregulation Predicts a Poor Prognosis and Associates with a Possible Mechanism for Paclitaxel Resistance in Ovarian Cancer. Journal of Clinical Medicine, 7(10), 330. https://doi.org/10.3390/jcm7100330